Description
ChemicalBook > CAS DataBase List > Dabrafenib Mesylate

Dabrafenib Mesylate

Description
Product Name
Dabrafenib Mesylate
CAS No.
1195768-06-9
Chemical Name
Dabrafenib Mesylate
Synonyms
Dabrafenib Mesylate;GSK 2118436B;Dapafini mesylate;abrafenibmesylate;Dabrfenib Mesylate;GSK2118436 Mesylate;GSK 2118436 Mesylate;GSK-2118436 Mesylate;Dabrafenib Mesylate (API);Debrafenib Mesylate (API)
CBNumber
CB72630077
Molecular Formula
C24H24F3N5O5S3
Formula Weight
615.66
MOL File
1195768-06-9.mol
More
Less

Dabrafenib Mesylate Property

Melting point:
>234oC (dec.)
storage temp. 
Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility 
DMSO (Slightly, Heated), Methanol (Slightly)
form 
White solid.
color 
White to Off-White
Stability:
Hygroscopic
InChI
InChI=1S/C23H20F3N5O2S2.CH4O3S/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25;1-5(2,3)4/h4-11,31H,1-3H3,(H2,27,28,29);1H3,(H,2,3,4)
InChIKey
YKGMKSIHIVVYKY-UHFFFAOYSA-N
SMILES
S(O)(=O)(=O)C.FC1C(=CC=CC=1C1N=C(C(C)(C)C)SC=1C1C=CN=C(N)N=1)NS(C1C(=CC=CC=1F)F)(=O)=O
More
Less

Safety

HS Code 
2935909099
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P302+P352IF ON SKIN: wash with plenty of soap and water.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Tocris
Product number
7223
Product name
Dabrafenibmesylate
Purity
≥98%(HPLC)
Packaging
50
Price
$149
Updated
2021/12/16
TRC
Product number
D101005
Product name
DabrafenibMesylate
Packaging
25mg
Price
$150
Updated
2021/12/16
Biosynth Carbosynth
Product number
FD158016
Product name
Dabrafenib mesylate
Packaging
25mg
Price
$187.5
Updated
2021/12/16
ChemScene
Product number
CS-1641
Product name
DabrafenibMesylate
Purity
99.94%
Packaging
50mg
Price
$100
Updated
2021/12/16
Apolloscientific
Product number
BISN0172
Product name
Dabrafenib Mesylate
Packaging
10mg
Price
$129
Updated
2021/12/16
More
Less

Dabrafenib Mesylate Chemical Properties,Usage,Production

Description

Dabrafenib Mesylate(1195768-06-9) is a salt form of Dabrafenib. Dabrafenib is an inhibitor of certain mutated forms of BRAF kinase, several of which may be associated with stimulating tumour growth (e.g. the BRAF V600E mutation), and Dabrafenib is also an inhibitor of BRAF V600-mutation positive cancer cell growth, both in vitro and in vivo.

Description

Dabrafenib mesylate, sold by GlaxoSmithKline under the trade name Tafinlar, was approved by the U.S. FDA in May 2013 for the treatment of metastatic BRAF-mutant melanoma. Dabrafenib reversibly inhibits the BRAF(V600E) mutant kinase as a selective ATP-competitive inhibitor which results in tumor regression.

Uses

Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.

Definition

ChEBI: A methanesulfonate (mesylate) salt prepared from equimolar amounts of dabrafenib and methanesulfonic acid. Used for treatment of metastatic melanoma.

Synthesis

Commercially available fluoroaniline 40 was first converted to sulfonamide 42 in 91% yield by treatment with 2,5-difluorobenzenesulfonyl chloride (41) in the presence of pyridine. Next, deprotonation of 2-chloro-4-methylpyrimidine (43) with lithium bis(trimethylsilyl)amide (LHMDS) followed by addition to ester 42 afforded chloropyrimidine 44 in 72% yield. Bromination followed by thiazole formation through the use of 2,2-dimethylpropanethioamide gave the penultimate target 45 in 80% over two steps. Chloropyrimidine 45 was subjected to SNAr conditions with ammonium hydroxide to furnish the aminopyrimidine in 88% yield, and this was followed by exposure to methanesulfonic acid to afford dabrafenib mesylate (VI) in 85% yield.

target

Raf

storage

Store at -20°C

References

[1]namba h, nakashima m, hayashi t, hayashida n, maeda s, rogounovitch ti, ohtsuru a, saenko va, kanematsu t, yamashita s. clinical implication of hot spot braf mutation, v599e, in papillary thyroid cancers. j. clin. endocrinol. metab. 2003; 88 (9): 4393–7.
[2]tan yh, liu y, eu kw, ang pw, li wq, salto-tellez m, iacopetta b, soong r. detection of braf v600e mutation by pyrosequencing. pathology 2008; 40 (3): 295–8.
[3]davies h, bignell gr, cox c, et al. mutations of the braf gene in human cancer. nature. 2002; 417: 949-954.
[4]ma xh, piao sf, dey s, mcafee q, karakousis g, villanueva j, hart ls, levi s, hu j, zhang g, lazova r, klump v, pawelek jm, xu x, xu w, schuchter lm, davies ma, herlyn m, winkler j, koumenis c, amaravadi rk. targeting er stress-induced autophagy overcomes braf inhibitor resistance in melanoma. j clin invest. 2014; 124(3): 1406-17.

Dabrafenib Mesylate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Dabrafenib Mesylate Suppliers

MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32165
Advantage
58
InvivoChem
Tel
+1-708-310-1919 +1-13798911105
Fax
708-557-7486
Email
sales@invivochem.cn
Country
United States
ProdList
6391
Advantage
58
Protheragen-ING
Tel
+16313385890
Email
info@protheragen-ing.com
Country
United States
ProdList
3868
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38632
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
BOC Sciences
Tel
16314854226
Email
info@bocsci.com
Country
United States
ProdList
9923
Advantage
65
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81
LC Laboratories
Tel
--
Fax
--
Email
custserv@lclabs.com
Country
United States
ProdList
503
Advantage
50
ChemShuttle. Inc.
Tel
--
Fax
--
Email
Sales@ChemShuttle.com
Country
United States
ProdList
6695
Advantage
58
Combi-Blocks Inc.
Tel
--
Fax
--
Email
sales@combi-blocks.com
Country
United States
ProdList
6618
Advantage
69
Matrix Scientific
Tel
--
Fax
--
Email
sales@matrixscientific.com
Country
United States
ProdList
6632
Advantage
80
ChemieTek
Tel
--
Fax
--
Email
info@chemietek.com
Country
United States
ProdList
219
Advantage
50
American Custom Chemicals Corporation
Tel
--
Fax
--
Email
sales@acccorporation.com
Country
United States
ProdList
6820
Advantage
51
LKT Laboratories, Inc.
Tel
--
Fax
--
Email
info@lktlabs.com
Country
United States
ProdList
2164
Advantage
64
More
Less

View Lastest Price from Dabrafenib Mesylate manufacturers

BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Product
Dabrafenib Mesylate 1195768-06-9
Price
US $1.00/g
Min. Order
5g
Purity
More Than 99%
Supply Ability
100kg/Month
Release date
2024-08-09
Zison Pharmaceutical (Shandong) Co., Ltd.
Product
Dabrafenib mesylate 1195768-06-9
Price
US $0.00-0.00/kg
Min. Order
1kg
Purity
>99.5% by HPLC
Supply Ability
100kg/month
Release date
2023-02-18
Zison Pharmaceutical (Shandong) Co., Ltd.
Product
Dabrafenib Mesylate 1195768-06-9
Price
US $0.00/g
Min. Order
10g
Purity
99.9
Supply Ability
20kgs
Release date
2024-05-24

1195768-06-9, Dabrafenib MesylateRelated Search:


  • Dabrafenib Mesylate (GSK-2118436)
  • Dabrafenib Mesylate(GSK-2118436B)
  • Dabrafenib Mesylate
  • GSK 2118436 Mesylate
  • GSK 2118436B
  • GSK2118436 Mesylate
  • GSK-2118436 Mesylate
  • Dabrafenib Mesylate (API)
  • GSK 2118436 methanesulfonate salt
  • N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide methanesulfonate
  • Dapafini mesylate
  • DABRAFENIB MESYLATE (GSK 2118436B);GSK-2118436 MESYLATE;GSK2118436 MESYLATE;GSK 2118436 MESYLATE
  • N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate
  • GSK2118436 Ms salt, Dabrafenib Ms salt, GSK2118436A Ms salt
  • Debrafenib Mesylate (API)
  • Dabrafenib, Methanesulfonate Salt
  • Dabrfenib Mesylate
  • N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzen
  • Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1)
  • abrafenibmesylate
  • Dabrafenib Mesylate (GSK2118436 Mesylate
  • N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonic acid
  • Dalafenib methanesulfonate
  • 1195768-06-9
  • C23H20F3N5O2S2CH4O3S
  • C24H24F3N5O5S3
  • Raf B protein kinase inhibitor
  • API